Paving the way for tomorrow’s cancer treatments
So many cancer clinical trials and research programs from yesterday are the treatments and cures of today. When you or a loved one is faced with a cancer diagnosis, you want access to the latest cancer trials, treatments and medicines.
You can help improve future cancer treatments while also gaining access to the latest care by participating in a clinical trial.
Because we participate in a number of national and international clinical research studies, you have an opportunity to receive the latest cancer treatment options. And our Novant Oncology Research Institute, a collaboration of cancer centers across our footprint, provides expanded access to clinical trials that advance cures while staying close to home.
Benefits of participating in clinical trials:
- Healthcare provided by leading physicians in the field of cancer research
- Access to new drugs and interventions before they are widely available
- Close monitoring of your healthcare and any side effects
- An opportunity to be the first to benefit from successful trials
- An opportunity to make a valuable contribution to cancer research
Today, hundreds of cancer patients currently are involved in clinical trials. Participating in a clinical trial is a very personal decision. We encourage you to speak with your healthcare team and loved ones before deciding how you would like to proceed.
Current clinical trials -
We have numerous clinical trials currently underway involving hundreds of patients. We update our list of clinical trials and availability on a monthly basis. See our current cancer clinical trials.
Frequently asked questions
What is a clinical trial? -
Clinical trials are research studies that involve patient volunteers to help find different ways to treat diseases such as cancer. Each study is designed to answer specific scientific questions and find better ways to prevent, diagnose or treat cancer.
Why are clinical trials important? -
Clinical trials are vital to the fight against cancer because they determine if a new treatment is safe and effective. Today’s research will help us improve tomorrow’s cancer care.
What happens during a clinical trial? -
When someone chooses participate in a clinical trial, the care they receive is much like the care they would otherwise receive. However, there is often additional monitoring to learn about the potential side effects and benefits of the clinical trial. Some trials study new drugs, devices or combination therapy. Throughout the trial, patients are monitored closely by their physician and research nurses who are specially trained in cancer research.
Should I participate in a clinical trial? -
This is a very personal decision. Your healthcare team can help you determine if a clinical trial is right for you. We encourage you to talk with your family and loved ones before deciding. Clinical trials may be found to be more or less effective than current standard treatments and may have side effects not yet known. You will be informed of these risks as much as possible, but be assured that your healthcare team will give you the information you need to make the decision that is right for you.
Guide to reading clinical trials
Learn how to read and understand cancer research clinical trials. »
Clinical trial phases
Phase 1 studies -
Phase 1 studies are the first introduction of an investigational new drug into humans. These studies are closely monitored and may be conducted in patients or normal volunteer subjects. Novant Health Cancer Care does not participate in Phase 1 studies.
Phase 2 studies -
Phase 2 studies are conducted to evaluate the effectiveness of a drug for a particular indication or indications in patients with the type of cancer under study. The goal of Phase 2 studies is to determine the common short-term side effects and risks (if any) associated with a new drug.
Phase 3 studies -
Phase 3 studies are performed after there is preliminary evidence suggesting that a new drug is effective for cancer treatment. In a Phase 3 study, researchers gather the additional information about the effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug. In addition, information from a Phase 3 study is used to provide guidelines for physician labeling.
Phase 4 (or post-marketing) studies -
After the Food & Drug Administration has approved a drug for marketing, Phase 4 studies gather additional information about the drug's risks, benefits and optimal use.
Glossary of cancer research terms
Visit our online Novant Health library to see a full glossary of terms on cancer research clinical trials.
Talk with your doctor to determine if a clinical trial could be right for you, or call our Novant Oncology Research Institute to learn more about current opportunities.